VitaNova Life Sciences (VNOV) Receivables - Other (2019 - 2026)

VitaNova Life Sciences' Receivables - Other history runs 4 years deep, the most recent figure standing at -$172310.0 for Q1 2026.

• Quarterly Receivables - Other changed N/A year-over-year to -$172310.0 in Q1 2026, while the trailing twelve-month figure through Jan 2026 was -$671782.0 (down 200.0% YoY) and the FY2025 annual result came in at -$302068.0, down 165.54% from the prior year.
• Receivables - Other was -$172310.0 for Q1 2026 at VitaNova Life Sciences, down from $13508.0 in the prior quarter.
• Across five years, Receivables - Other topped out at $460870.0 in Q2 2024 and bottomed at -$512980.0 in Q2 2025.
• A 3-year average of $22285.7 and a median of $13508.0 in 2025 frame the typical range for Receivables - Other.
• Peak annual rise in Receivables - Other reached 108.02% in 2025, while the deepest fall reached 211.31% in 2025.
• VitaNova Life Sciences' Receivables - Other stood at -$168480.0 in 2024, then surged by 108.02% to $13508.0 in 2025, then tumbled by 1375.61% to -$172310.0 in 2026.
• Business Quant data shows VNOV's Receivables - Other at -$172310.0 in Q1 2026, $13508.0 in Q4 2025, and -$512980.0 in Q2 2025.